IL109614A - Comestible products containing saponins - Google Patents
Comestible products containing saponinsInfo
- Publication number
- IL109614A IL109614A IL109614A IL10961494A IL109614A IL 109614 A IL109614 A IL 109614A IL 109614 A IL109614 A IL 109614A IL 10961494 A IL10961494 A IL 10961494A IL 109614 A IL109614 A IL 109614A
- Authority
- IL
- Israel
- Prior art keywords
- hydrogen
- saponin
- saponins
- methyl
- fenugreek
- Prior art date
Links
- 150000007949 saponins Chemical class 0.000 title claims abstract description 74
- 229930182490 saponin Natural products 0.000 title claims abstract description 73
- 235000017709 saponins Nutrition 0.000 title claims abstract description 73
- 229910052739 hydrogen Inorganic materials 0.000 claims abstract description 36
- 239000001397 quillaja saponaria molina bark Substances 0.000 claims abstract description 35
- 244000250129 Trigonella foenum graecum Species 0.000 claims abstract description 32
- 235000001484 Trigonella foenum graecum Nutrition 0.000 claims abstract description 30
- 235000001019 trigonella foenum-graecum Nutrition 0.000 claims abstract description 30
- 239000001257 hydrogen Substances 0.000 claims abstract description 24
- 239000008103 glucose Substances 0.000 claims abstract description 13
- 239000000203 mixture Substances 0.000 claims abstract description 9
- 235000010469 Glycine max Nutrition 0.000 claims abstract description 8
- 244000068988 Glycine max Species 0.000 claims abstract description 7
- 125000004435 hydrogen atom Chemical group [H]* 0.000 claims abstract description 7
- SRBFZHDQGSBBOR-IOVATXLUSA-N D-xylopyranose Chemical compound O[C@@H]1COC(O)[C@H](O)[C@H]1O SRBFZHDQGSBBOR-IOVATXLUSA-N 0.000 claims abstract description 6
- 239000003995 emulsifying agent Substances 0.000 claims abstract description 6
- 150000003431 steroids Chemical class 0.000 claims abstract description 5
- WQZGKKKJIJFFOK-QTVWNMPRSA-N D-mannopyranose Chemical compound OC[C@H]1OC(O)[C@@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-QTVWNMPRSA-N 0.000 claims abstract description 3
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 claims abstract description 3
- WQZGKKKJIJFFOK-PHYPRBDBSA-N alpha-D-galactose Chemical compound OC[C@H]1O[C@H](O)[C@H](O)[C@@H](O)[C@H]1O WQZGKKKJIJFFOK-PHYPRBDBSA-N 0.000 claims abstract description 3
- PYMYPHUHKUWMLA-UHFFFAOYSA-N arabinose Natural products OCC(O)C(O)C(O)C=O PYMYPHUHKUWMLA-UHFFFAOYSA-N 0.000 claims abstract description 3
- SRBFZHDQGSBBOR-UHFFFAOYSA-N beta-D-Pyranose-Lyxose Natural products OC1COC(O)C(O)C1O SRBFZHDQGSBBOR-UHFFFAOYSA-N 0.000 claims abstract description 3
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 claims abstract description 3
- 229930182830 galactose Natural products 0.000 claims abstract description 3
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 claims description 25
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 claims description 10
- WQLVFSAGQJTQCK-UHFFFAOYSA-N diosgenin Natural products CC1C(C2(CCC3C4(C)CCC(O)CC4=CCC3C2C2)C)C2OC11CCC(C)CO1 WQLVFSAGQJTQCK-UHFFFAOYSA-N 0.000 claims description 8
- 150000002431 hydrogen Chemical group 0.000 claims description 7
- FWCXELAAYFYCSR-UHFFFAOYSA-N Episamogenin Natural products CC1C(C2(CCC3C4(C)CC(O)C(O)CC4CCC3C2C2)C)C2OC11CCC(C)CO1 FWCXELAAYFYCSR-UHFFFAOYSA-N 0.000 claims description 6
- RTMWIZOXNKJHRE-UHFFFAOYSA-N Tigogenin Natural products CC1COC2CC(C)(OC12)C3CCC4C5CCC6CC(O)CCC6(C)C5CCC34C RTMWIZOXNKJHRE-UHFFFAOYSA-N 0.000 claims description 6
- WQLVFSAGQJTQCK-CAKNJAFZSA-N Yamogenin Chemical compound O([C@@H]1[C@@H]([C@]2(CC[C@@H]3[C@@]4(C)CC[C@H](O)CC4=CC[C@H]3[C@@H]2C1)C)[C@@H]1C)[C@]11CC[C@H](C)CO1 WQLVFSAGQJTQCK-CAKNJAFZSA-N 0.000 claims description 6
- 125000002887 hydroxy group Chemical group [H]O* 0.000 claims description 5
- DWCSNWXARWMZTG-UHFFFAOYSA-N Trigonegenin A Natural products CC1C(C2(CCC3C4(C)CCC(O)C=C4CCC3C2C2)C)C2OC11CCC(C)CO1 DWCSNWXARWMZTG-UHFFFAOYSA-N 0.000 claims description 4
- JLISZLJGTVNTPC-UBWBUNFISA-N Yuccagenin Chemical group C[C@@H]1CC[C@@]2(OC1)O[C@H]3C[C@H]4[C@@H]5CCC6=C[C@@H](O)[C@H](O)C[C@]6(C)[C@H]5CC[C@]4(C)[C@H]3[C@@H]2C JLISZLJGTVNTPC-UBWBUNFISA-N 0.000 claims description 4
- WQLVFSAGQJTQCK-VKROHFNGSA-N diosgenin Chemical compound O([C@@H]1[C@@H]([C@]2(CC[C@@H]3[C@@]4(C)CC[C@H](O)CC4=CC[C@H]3[C@@H]2C1)C)[C@@H]1C)[C@]11CC[C@@H](C)CO1 WQLVFSAGQJTQCK-VKROHFNGSA-N 0.000 claims description 4
- ORXKASWXOVPKDV-CTGSJARNSA-N (1S,2S,4S,5'S,6R,7S,8R,9S,12S,13R,15R,16R)-5',7,9,13-tetramethylspiro[5-oxapentacyclo[10.8.0.02,9.04,8.013,18]icos-18-ene-6,2'-oxane]-15,16-diol Chemical group O([C@@H]1[C@@H]([C@]2(CC[C@@H]3[C@@]4(C)C[C@@H](O)[C@H](O)CC4=CC[C@H]3[C@@H]2C1)C)[C@@H]1C)[C@]11CC[C@H](C)CO1 ORXKASWXOVPKDV-CTGSJARNSA-N 0.000 claims description 3
- FWCXELAAYFYCSR-RYKNUXCGSA-N Gitogenin Chemical compound O([C@@H]1[C@@H]([C@]2(CC[C@@H]3[C@@]4(C)C[C@@H](O)[C@H](O)C[C@@H]4CC[C@H]3[C@@H]2C1)C)[C@@H]1C)[C@]11CC[C@@H](C)CO1 FWCXELAAYFYCSR-RYKNUXCGSA-N 0.000 claims description 3
- ZVWCWPUAQHAINU-UHFFFAOYSA-N Gitogenin Natural products CC1CCC2(CC3OC4C5CCC6CC(O)C(O)CC6(C)C5CCC4(C)C3C2C)OC1 ZVWCWPUAQHAINU-UHFFFAOYSA-N 0.000 claims description 3
- FWCXELAAYFYCSR-HJXRQQMRSA-N Neogitogenin Chemical compound O([C@@H]1[C@@H]([C@]2(CC[C@@H]3[C@@]4(C)C[C@@H](O)[C@H](O)C[C@@H]4CC[C@H]3[C@@H]2C1)C)[C@@H]1C)[C@]11CC[C@H](C)CO1 FWCXELAAYFYCSR-HJXRQQMRSA-N 0.000 claims description 3
- GMBQZIIUCVWOCD-PUHUBZITSA-N Neotigogenin Chemical compound O([C@@H]1[C@@H]([C@]2(CC[C@@H]3[C@@]4(C)CC[C@H](O)C[C@@H]4CC[C@H]3[C@@H]2C1)C)[C@@H]1C)[C@]11CC[C@H](C)CO1 GMBQZIIUCVWOCD-PUHUBZITSA-N 0.000 claims description 3
- GMBQZIIUCVWOCD-WWASVFFGSA-N Sarsapogenine Chemical compound O([C@@H]1[C@@H]([C@]2(CC[C@@H]3[C@@]4(C)CC[C@H](O)C[C@H]4CC[C@H]3[C@@H]2C1)C)[C@@H]1C)[C@]11CC[C@H](C)CO1 GMBQZIIUCVWOCD-WWASVFFGSA-N 0.000 claims description 3
- SHZGCJCMOBCMKK-UHFFFAOYSA-N D-mannomethylose Natural products CC1OC(O)C(O)C(O)C1O SHZGCJCMOBCMKK-UHFFFAOYSA-N 0.000 claims description 2
- SHZGCJCMOBCMKK-JFNONXLTSA-N L-rhamnopyranose Chemical compound C[C@@H]1OC(O)[C@H](O)[C@H](O)[C@H]1O SHZGCJCMOBCMKK-JFNONXLTSA-N 0.000 claims description 2
- PNNNRSAQSRJVSB-UHFFFAOYSA-N L-rhamnose Natural products CC(O)C(O)C(O)C(O)C=O PNNNRSAQSRJVSB-UHFFFAOYSA-N 0.000 claims description 2
- 238000000034 method Methods 0.000 claims description 2
- 239000002904 solvent Substances 0.000 claims description 2
- -1 rhamanose Chemical compound 0.000 abstract 1
- BGHCVCJVXZWKCC-UHFFFAOYSA-N tetradecane Chemical compound CCCCCCCCCCCCCC BGHCVCJVXZWKCC-UHFFFAOYSA-N 0.000 description 18
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 17
- 239000000839 emulsion Substances 0.000 description 15
- 235000013305 food Nutrition 0.000 description 11
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 9
- VLKZOEOYAKHREP-UHFFFAOYSA-N n-Hexane Chemical compound CCCCCC VLKZOEOYAKHREP-UHFFFAOYSA-N 0.000 description 8
- 229930188627 soysaponin Natural products 0.000 description 8
- 239000003921 oil Substances 0.000 description 7
- 235000019198 oils Nutrition 0.000 description 7
- 241000196324 Embryophyta Species 0.000 description 6
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 6
- 230000000694 effects Effects 0.000 description 6
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 5
- 238000004945 emulsification Methods 0.000 description 5
- INLFWQCRAJUDCR-IQVMEADQSA-N (1R,2S,4S,5'S,6R,7S,8R,9S,12S,13S)-5',7,9,13-tetramethylspiro[5-oxapentacyclo[10.8.0.02,9.04,8.013,18]icosane-6,2'-oxane] Chemical compound O([C@@H]1[C@@H]([C@]2(CC[C@@H]3[C@@]4(C)CCCCC4CC[C@H]3[C@@H]2C1)C)[C@@H]1C)[C@]11CC[C@H](C)CO1 INLFWQCRAJUDCR-IQVMEADQSA-N 0.000 description 4
- IIZPXYDJLKNOIY-JXPKJXOSSA-N 1-palmitoyl-2-arachidonoyl-sn-glycero-3-phosphocholine Chemical class CCCCCCCCCCCCCCCC(=O)OC[C@H](COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCC\C=C/C\C=C/C\C=C/C\C=C/CCCCC IIZPXYDJLKNOIY-JXPKJXOSSA-N 0.000 description 4
- NWGKJDSIEKMTRX-AAZCQSIUSA-N Sorbitan monooleate Chemical compound CCCCCCCC\C=C/CCCCCCCC(=O)OC[C@@H](O)[C@H]1OC[C@H](O)[C@H]1O NWGKJDSIEKMTRX-AAZCQSIUSA-N 0.000 description 4
- 235000016709 nutrition Nutrition 0.000 description 4
- 238000012552 review Methods 0.000 description 4
- 239000004094 surface-active agent Substances 0.000 description 4
- UHOVQNZJYSORNB-UHFFFAOYSA-N Benzene Chemical compound C1=CC=CC=C1 UHOVQNZJYSORNB-UHFFFAOYSA-N 0.000 description 3
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 3
- 239000002537 cosmetic Substances 0.000 description 3
- 230000002209 hydrophobic effect Effects 0.000 description 3
- 150000002632 lipids Chemical class 0.000 description 3
- 230000035764 nutrition Effects 0.000 description 3
- ALSTYHKOOCGGFT-KTKRTIGZSA-N (9Z)-octadecen-1-ol Chemical class CCCCCCCC\C=C/CCCCCCCCO ALSTYHKOOCGGFT-KTKRTIGZSA-N 0.000 description 2
- QRLVDLBMBULFAL-UHFFFAOYSA-N Digitonin Natural products CC1CCC2(OC1)OC3C(O)C4C5CCC6CC(OC7OC(CO)C(OC8OC(CO)C(O)C(OC9OCC(O)C(O)C9OC%10OC(CO)C(O)C(OC%11OC(CO)C(O)C(O)C%11O)C%10O)C8O)C(O)C7O)C(O)CC6(C)C5CCC4(C)C3C2C QRLVDLBMBULFAL-UHFFFAOYSA-N 0.000 description 2
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 2
- 235000014647 Lens culinaris subsp culinaris Nutrition 0.000 description 2
- 244000043158 Lens esculenta Species 0.000 description 2
- 240000004713 Pisum sativum Species 0.000 description 2
- 235000010582 Pisum sativum Nutrition 0.000 description 2
- UVYVLBIGDKGWPX-KUAJCENISA-N digitonin Chemical compound O([C@@H]1[C@@H]([C@]2(CC[C@@H]3[C@@]4(C)C[C@@H](O)[C@H](O[C@H]5[C@@H]([C@@H](O)[C@@H](O[C@H]6[C@@H]([C@@H](O[C@H]7[C@@H]([C@@H](O)[C@H](O)CO7)O)[C@H](O)[C@@H](CO)O6)O[C@H]6[C@@H]([C@@H](O[C@H]7[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O7)O)[C@@H](O)[C@@H](CO)O6)O)[C@@H](CO)O5)O)C[C@@H]4CC[C@H]3[C@@H]2[C@@H]1O)C)[C@@H]1C)[C@]11CC[C@@H](C)CO1 UVYVLBIGDKGWPX-KUAJCENISA-N 0.000 description 2
- UVYVLBIGDKGWPX-UHFFFAOYSA-N digitonine Natural products CC1C(C2(CCC3C4(C)CC(O)C(OC5C(C(O)C(OC6C(C(OC7C(C(O)C(O)CO7)O)C(O)C(CO)O6)OC6C(C(OC7C(C(O)C(O)C(CO)O7)O)C(O)C(CO)O6)O)C(CO)O5)O)CC4CCC3C2C2O)C)C2OC11CCC(C)CO1 UVYVLBIGDKGWPX-UHFFFAOYSA-N 0.000 description 2
- 230000001804 emulsifying effect Effects 0.000 description 2
- 150000002148 esters Chemical class 0.000 description 2
- 238000000605 extraction Methods 0.000 description 2
- 238000005187 foaming Methods 0.000 description 2
- 238000002955 isolation Methods 0.000 description 2
- 235000010445 lecithin Nutrition 0.000 description 2
- 239000000787 lecithin Substances 0.000 description 2
- 229940067606 lecithin Drugs 0.000 description 2
- 235000013336 milk Nutrition 0.000 description 2
- 239000008267 milk Substances 0.000 description 2
- 210000004080 milk Anatomy 0.000 description 2
- 239000002736 nonionic surfactant Substances 0.000 description 2
- 239000000825 pharmaceutical preparation Substances 0.000 description 2
- WTJKGGKOPKCXLL-RRHRGVEJSA-N phosphatidylcholine Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@H](COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCCCCCCC=CCCCCCCCC WTJKGGKOPKCXLL-RRHRGVEJSA-N 0.000 description 2
- 230000000704 physical effect Effects 0.000 description 2
- 230000001766 physiological effect Effects 0.000 description 2
- BASFCYQUMIYNBI-UHFFFAOYSA-N platinum Chemical compound [Pt] BASFCYQUMIYNBI-UHFFFAOYSA-N 0.000 description 2
- 235000010482 polyoxyethylene sorbitan monooleate Nutrition 0.000 description 2
- 229920000053 polysorbate 80 Polymers 0.000 description 2
- 238000000926 separation method Methods 0.000 description 2
- 239000007787 solid Substances 0.000 description 2
- 239000000243 solution Substances 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- 230000002195 synergetic effect Effects 0.000 description 2
- JNYAEWCLZODPBN-JGWLITMVSA-N (2r,3r,4s)-2-[(1r)-1,2-dihydroxyethyl]oxolane-3,4-diol Chemical class OC[C@@H](O)[C@H]1OC[C@H](O)[C@H]1O JNYAEWCLZODPBN-JGWLITMVSA-N 0.000 description 1
- ZORQXIQZAOLNGE-UHFFFAOYSA-N 1,1-difluorocyclohexane Chemical class FC1(F)CCCCC1 ZORQXIQZAOLNGE-UHFFFAOYSA-N 0.000 description 1
- LDVVTQMJQSCDMK-UHFFFAOYSA-N 1,3-dihydroxypropan-2-yl formate Chemical compound OCC(CO)OC=O LDVVTQMJQSCDMK-UHFFFAOYSA-N 0.000 description 1
- SMRPGWBDLOQHOS-UHFFFAOYSA-N 5-[4,5-dihydroxy-6-(hydroxymethyl)-3-(3,4,5-trihydroxy-6-methyloxan-2-yl)oxyoxan-2-yl]oxy-3,4-dihydroxy-6-[[9-hydroxy-4-(hydroxymethyl)-4,6a,6b,8a,11,11,14b-heptamethyl-14-oxo-2,3,4a,5,6,7,8,9,10,12,12a,14a-dodecahydro-1H-picen-3-yl]oxy]oxane-2-carboxylic acid Chemical compound OC1C(O)C(O)C(C)OC1OC1C(OC2C(OC(C(O)C2O)C(O)=O)OC2C(C3C(C4C(C5(CCC6(C)C(O)CC(C)(C)CC6C5=CC4=O)C)(C)CC3)(C)CC2)(C)CO)OC(CO)C(O)C1O SMRPGWBDLOQHOS-UHFFFAOYSA-N 0.000 description 1
- 101710095342 Apolipoprotein B Proteins 0.000 description 1
- 102100040202 Apolipoprotein B-100 Human genes 0.000 description 1
- 244000105624 Arachis hypogaea Species 0.000 description 1
- 229920000926 Galactomannan Polymers 0.000 description 1
- JZNWSCPGTDBMEW-UHFFFAOYSA-N Glycerophosphorylethanolamin Natural products NCCOP(O)(=O)OCC(O)CO JZNWSCPGTDBMEW-UHFFFAOYSA-N 0.000 description 1
- 241001316290 Gypsophila Species 0.000 description 1
- 241000282414 Homo sapiens Species 0.000 description 1
- 208000000563 Hyperlipoproteinemia Type II Diseases 0.000 description 1
- 206010023230 Joint stiffness Diseases 0.000 description 1
- 108010028554 LDL Cholesterol Proteins 0.000 description 1
- 240000004658 Medicago sativa Species 0.000 description 1
- 235000017587 Medicago sativa ssp. sativa Nutrition 0.000 description 1
- 241000700159 Rattus Species 0.000 description 1
- CWHJIJJSDGEHNS-MYLFLSLOSA-N Senegenin Chemical compound C1[C@H](O)[C@H](O)[C@@](C)(C(O)=O)[C@@H]2CC[C@@]3(C)C(CC[C@]4(CCC(C[C@H]44)(C)C)C(O)=O)=C4[C@@H](CCl)C[C@@H]3[C@]21C CWHJIJJSDGEHNS-MYLFLSLOSA-N 0.000 description 1
- XUIMIQQOPSSXEZ-UHFFFAOYSA-N Silicon Chemical compound [Si] XUIMIQQOPSSXEZ-UHFFFAOYSA-N 0.000 description 1
- 229930182558 Sterol Natural products 0.000 description 1
- 206010045254 Type II hyperlipidaemia Diseases 0.000 description 1
- ORXKASWXOVPKDV-UBWBUNFISA-N Yuccagenin Chemical compound O([C@@H]1[C@@H]([C@]2(CC[C@@H]3[C@@]4(C)C[C@@H](O)[C@H](O)CC4=CC[C@H]3[C@@H]2C1)C)[C@@H]1C)[C@]11CC[C@@H](C)CO1 ORXKASWXOVPKDV-UBWBUNFISA-N 0.000 description 1
- FOLJTMYCYXSPFQ-CJKAUBRRSA-N [(2r,3s,4s,5r,6r)-6-[(2s,3s,4s,5r)-3,4-dihydroxy-5-(hydroxymethyl)-2-(octadecanoyloxymethyl)oxolan-2-yl]oxy-3,4,5-trihydroxyoxan-2-yl]methyl octadecanoate Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](COC(=O)CCCCCCCCCCCCCCCCC)O[C@@H]1O[C@@]1(COC(=O)CCCCCCCCCCCCCCCCC)[C@@H](O)[C@H](O)[C@@H](CO)O1 FOLJTMYCYXSPFQ-CJKAUBRRSA-N 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 229930013930 alkaloid Natural products 0.000 description 1
- 239000008346 aqueous phase Substances 0.000 description 1
- 239000007864 aqueous solution Substances 0.000 description 1
- 239000010426 asphalt Substances 0.000 description 1
- 235000013361 beverage Nutrition 0.000 description 1
- 150000001720 carbohydrates Chemical class 0.000 description 1
- 235000014633 carbohydrates Nutrition 0.000 description 1
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 description 1
- 235000012000 cholesterol Nutrition 0.000 description 1
- 239000000084 colloidal system Substances 0.000 description 1
- 230000000536 complexating effect Effects 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 239000006071 cream Substances 0.000 description 1
- 235000005911 diet Nutrition 0.000 description 1
- 230000000378 dietary effect Effects 0.000 description 1
- 239000006185 dispersion Substances 0.000 description 1
- 235000013399 edible fruits Nutrition 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- BEFDCLMNVWHSGT-UHFFFAOYSA-N ethenylcyclopentane Chemical compound C=CC1CCCC1 BEFDCLMNVWHSGT-UHFFFAOYSA-N 0.000 description 1
- 238000011156 evaluation Methods 0.000 description 1
- 239000004744 fabric Substances 0.000 description 1
- 239000000796 flavoring agent Substances 0.000 description 1
- 235000019634 flavors Nutrition 0.000 description 1
- 239000006260 foam Substances 0.000 description 1
- 239000004088 foaming agent Substances 0.000 description 1
- 235000011187 glycerol Nutrition 0.000 description 1
- 229930182470 glycoside Natural products 0.000 description 1
- 150000002338 glycosides Chemical class 0.000 description 1
- 208000019622 heart disease Diseases 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- 150000002402 hexoses Chemical class 0.000 description 1
- 239000008173 hydrogenated soybean oil Substances 0.000 description 1
- 230000000871 hypocholesterolemic effect Effects 0.000 description 1
- 238000011534 incubation Methods 0.000 description 1
- 239000003350 kerosene Substances 0.000 description 1
- 235000021374 legumes Nutrition 0.000 description 1
- 210000004185 liver Anatomy 0.000 description 1
- 229920002521 macromolecule Polymers 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 150000004702 methyl esters Chemical class 0.000 description 1
- 238000002156 mixing Methods 0.000 description 1
- 238000000329 molecular dynamics simulation Methods 0.000 description 1
- 238000000302 molecular modelling Methods 0.000 description 1
- 231100000252 nontoxic Toxicity 0.000 description 1
- 230000003000 nontoxic effect Effects 0.000 description 1
- 239000007764 o/w emulsion Substances 0.000 description 1
- 229940049964 oleate Drugs 0.000 description 1
- ZQPPMHVWECSIRJ-KTKRTIGZSA-N oleic acid Chemical compound CCCCCCCC\C=C/CCCCCCCC(O)=O ZQPPMHVWECSIRJ-KTKRTIGZSA-N 0.000 description 1
- 239000003960 organic solvent Substances 0.000 description 1
- 235000020232 peanut Nutrition 0.000 description 1
- 239000012071 phase Substances 0.000 description 1
- 150000008104 phosphatidylethanolamines Chemical class 0.000 description 1
- 229910052697 platinum Inorganic materials 0.000 description 1
- 244000144977 poultry Species 0.000 description 1
- 239000000843 powder Substances 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- 238000000746 purification Methods 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- NWMIYTWHUDFRPL-UHFFFAOYSA-N sapogenin Natural products COC(=O)C1(CO)C(O)CCC2(C)C1CCC3(C)C2CC=C4C5C(C)(O)C(C)CCC5(CCC34C)C(=O)O NWMIYTWHUDFRPL-UHFFFAOYSA-N 0.000 description 1
- PPRSVUXPYPBULA-UHFFFAOYSA-N saponin A Natural products CC1(C)CCC2(CCC3(C)C(=CCC4C5(C)CCC(OC6OC(CO)C(O)C(O)C6=O)C(C)(C)C5CCC34C)C2C1)C(=O)O PPRSVUXPYPBULA-UHFFFAOYSA-N 0.000 description 1
- 229940048730 senega Drugs 0.000 description 1
- 230000035945 sensitivity Effects 0.000 description 1
- 229910052710 silicon Inorganic materials 0.000 description 1
- 239000010703 silicon Substances 0.000 description 1
- 239000000344 soap Substances 0.000 description 1
- 235000010199 sorbic acid Nutrition 0.000 description 1
- 229940075582 sorbic acid Drugs 0.000 description 1
- 239000004334 sorbic acid Substances 0.000 description 1
- 125000002345 steroid group Chemical group 0.000 description 1
- 150000003432 sterols Chemical class 0.000 description 1
- 235000003702 sterols Nutrition 0.000 description 1
- 238000003756 stirring Methods 0.000 description 1
- 150000005846 sugar alcohols Polymers 0.000 description 1
- 238000012360 testing method Methods 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J71/00—Steroids in which the cyclopenta(a)hydrophenanthrene skeleton is condensed with a heterocyclic ring
- C07J71/0005—Oxygen-containing hetero ring
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
- A23L29/00—Foods or foodstuffs containing additives; Preparation or treatment thereof
- A23L29/10—Foods or foodstuffs containing additives; Preparation or treatment thereof containing emulsifiers
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Nutrition Science (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Food Science & Technology (AREA)
- Polymers & Plastics (AREA)
- General Health & Medical Sciences (AREA)
- Emulsifying, Dispersing, Foam-Producing Or Wetting Agents (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
The invention provides a comestible product comprising a fenugreek saponin as an emulsifying agent therein, said fenugreek saponin comprising a mixture of glucosidic steroids having formula (Ia or Ib) wherein R1, R2 and R3 are H, CH3, H; CH3, H, H; H, CH3, OH; or CH3, H, H respectively; and R4 is hydrogen or a unit of 2-5 interconnected sugar moieties, the moieties comprising mannose, glucose, rhamanose, xylose and galactose, and having different and improved properties when compared to products produced with soybean saponins.
[WO9530341A1]
Description
109,614/2 COMESTIBLE PRODUCTS CONTAINING SAPONINS twma? Ο^ ΏΓΪ Ό^ Η ο ^ » The present invention relates to comestible products. More particularly, the present invention relates to comestible products containing a saponin.
Japanese Patent 1,176,442 (CA112( 22) :204453r) describes an oil-in-water emulsion useful in cosmetic, food, and pharmaceutical preparations, prepared by heating a hydrogenated lecithin, saponin and polyhydric alcohol, dissolving them, and slowly adding an oil with constant stirring, followed by water, to form a stable emulsion. Thus, a stable emulsion consisting of 3.0 wt.% hydrogenated lecithin A, 0.6 wt.% saponin A, 60.0 wt.% glycerin, and 36.4 wt.% sgualane, is prepared.
Japanese Patent 2,258,044 ( CA114 ( 9 ): 80302k) describes the preparation of an emulsion prepared by mixing an oil phase containing phosphatidylcholine or phosphatidylethanol-amine and an aqueous phase containing saponins. The emulsion is useful in food, cosmetic, and pharmaceutical preparations. For example, 0.3 wt.% phosphatidylcholine was added to 300 g hydrogenated soybean oil, mixed with 700 g defatted milk containing 0.1 wt.% soybean saponins and 0.1 wt.% milk flavor, and homogenized to give a cream beverage .
Thus, the use of saponins from lecithin or soybean origin as emulsifying agents for use in food products is described in the literature.
The name "saponin" is given to substances whose properties have a certain analogy with those of soap: i.e., they have the ability to lower the surface tension of water, to foam, and to emulsify oils.
Saponins are sterols or triterpene glycosides [J.E. Courtois, et al., "Complex Glycosides," in The Carbohydrates Chemistry Biochemistry, 2nd Ed., Vol. IIA, W. Pigman and D. Horton, Eds., Academic Press, New York, pp. 213-240 (1970)], mainly of plant origin [E. Heftmann, "C2V Saponin and Alkaloids," in Steroid Biochemistry, Academic Press, New York, pp. 37-49 (1970)], and occurring in a variety of plants. Twenty-eight plant species containing saponins have been mentioned in Oxford Book of Plants [Oxford University Press, London (1969)]; the most significant sources of saponins in foods are legumes, such as soybeans, chick peas, peanuts and lentils. Saponins are non-toxic to human beings and are known to lower plasma cholesterol concentrations [H.A. Newman, et al., "Dietary Saponin, A Factor Which May Reduce Liver and Serum Cholesterol Levels," Poultry Sci., Vol. 37, pp. 42-45 (1957); J. Molgaard, et al., "Alfalfa Seeds Lower Low Density Lipoprotein Cholesterol and Apolipoprotein B Concentrations in Patients with Type II Hyperlipoproteinemia," Arthrosclerosis , Vol. 65, pp. 173-179 (1987)]. It has therefore been recommended to consume food rich in saponins to reduce the risk of heart disease [P.R. Cheeke, "Nutritional and Physiological Properties of Saponins," Nutrition Reports International, Vol. 13, pp. 360-365 (1976)].
In a recent review article on saponins in food, the chemical, physical and physiological properties of various saponins are discussed [D. Oakenfull, "Saponins in Food - A Review," Food Chemistry, Vol. 6, pp. 19-40 (1981)].
The isolation of saponins from plant materials by extraction is quite tedious and requires the use of organic solvents such as hexane or diethyl ether to remove the lipids, followed by the use of methanol to give the crude saponins [D. Oakenfull, "Saponins in Food - A Review," Food Chemistry, Vol. 6, pp. 19-40 (1981)]. Further purification is difficult, and was achieved by complexing the saponin with cholesterol. The removal of color and odor components requires further treatment.
The foaming power and emulsifying properties of soy saponins, and their possible use as naturally-occuring foaming agents, have drawn the attention of many investigators, and many patents have been registered thereon [for example, F.S. Rostler, et al., "Emulsions for Treating Asphalt Structures," U.S. Patent No. 3,766,107]. It is quite clear from these patents that saponins have potential in the food, cosmetics and pharmaceutical industries [A. Jacques, et al., "Stable Aqueous Fabric Softening Composition Based on Lecithin, Saponin and Sorbic Acid," U.S. Patent No. 4,808,320]. However, few scientific studies are available .
Ruyssen and Loos ["Properties of Saponins, Surface Activity and Degree of Dispersion," J. Colloid. Sci . , Vol. 2, pp. 429-451 (1947)] carried out a study on four selected saponins: sapoalbin (the acid form), extracted from the roots of the Gypsophilia species; senegin, which was prepared from the roots of Polyagola senega; digitonin, obtained from Digitoninum cryst; and blighiin, extracted from the fruit shell of the Congolese plant Bliighi Laurentii . It was clearly seen that surface tensions were lowered to values in the range of 55 to 42 dyn/cm. The surface area for sapoalbin was 0.569 nm2. The interfacial tension of water/benzene was reduced to about 5 dyn/cm. The emulsification ability was not studied. 4 109,614/2 According to the present invention, there is now provided a comestible product comprising a saponin as an emulsifying agent therein characterized in that the saponin is derived from fenugreek, said fenugreek saponin comprising a mixture of glucosidic steroids having the formula la or lb: wherein: Rl5 R2 and R3 are H, CH3, H; CH3, H, H; H, CH3, OH; or CH3, H, H, respectively; and R4 is hydrogen or a unit of 2-5 interconnected sugar moieties, said moieties comprising mannose, glucose, rhamnose, xylose and galactose, the 5 109,614/2 saponin being obtainable by a solvent abstraction process as described herein, and having different and improved properties when compared to products produced with soybean saponins.
Saponin from fenugreek grown in India was found to contain 5-6% steroid sapogenins, which percent is subdivided and composed of tigogenin (10.2%), neotigogenin (7.8%), diosgenin (40.3%), yamogenin (16.1%) and gitogenin (12%), together with some other sapogenins such as yuccagenin, neogitogenin and lilagenin, which were present in minor percentages. These sapogenic structures are quite different from those of soy saponins.
Thus, a first class of preferred embodiments of the present invention is the sapogenins of formula la, selected from the group consisting of tigogenin, wherein R[ is hydrogen; R2 is methyl; R3 is hydrogen and R4 includes 2-glucose, 2-galactose and 1-xylose; neotigogenin, wherein Ri is methyl; R2 and R3 are both hydrogen, and R4 includes 2-xylose, 1 -glucose and 1-rhamnose; gitogenin, wherein Ri is hydrogen; R2 is methyl; R3 is hydroxy and R4 includes 2-galactose, 1-xylose and 1 -glucose; and neogitogenin, wherein Ri is methyl and R2, R3 and R4 are each hydrogen.
A second class of preferred embodiments of the present invention is the sapogenins of formula lb, selected from the group consisting of diosgenin,, wherein R! is hydrogen; R2 is methyl; R3 is hydrogen and R4 includes 1-mannose, 1 -glucose, and 1-rhamnose; yamogenin, wherein Rj is methyl; R2 and R3 are both hydrogen, and R4 includes 2-rhamnose and 2-glucose; yucagenin, wherein R^. is hydrogen; R2 is methyl, R3 is hydroxy; and lilagenin, wherein Ra is methyl and R2, R3 and R4 are each hydrogen.
As is known, saponins are amphiphilic compounds in which the polar hexoses are linked to a non-polar steroid group (the sapogenin) . The nature of the saponin dominates its physical properties: it is strongly surface active, reducing water surface tension when 1% is added to water to 28 dyn/cm, and reducing interfacial tension from 44 dyn/cm to 8 dyn/cm in a tetradecane/water system, and has the ability to emulsify oils in the presence of hydrophobic surfactants. The HLB of the fenugreek saponin was found to be 18. The extracted saponin stabilizes oil in water emulsions together with Span 80 better than any other tested combinations of emulsifiers. Models constructed on the basis of molecular dynamics exhibit excellent structural fitness.
In Hyomen, Vol. 29, No. 7, pp. 559-570 (1991), as abstracted in CA117 : 114014x, there is described a review of 81 references on molecular structure, surface activity, and foaming and emulsifying power of soy saponins, effect of carboxy groups on the surface activity of soy saponin, and surface activity of soy saponin methyl ester and soy lipids. In said article there is described the testing of three types of soy saponins, wherein the best lowering of surface tension was achieved with the soy saponin designated SAb, which reduced water surface tension from 72.8 to 40 dyn/cm at 1% concentration.
In contradistinction thereto, the fenugreek saponins of the present invention were found to reduce water surface tension from 72.8 to 28 dyn/cm at 1% concentration. , - 7 - Similarly, the interfacial tension of SAb reached 10 dyn/cm in a kerosene/water system, while the fenugreek saponins of the present invention reached an interfacial tension of 8 dyn/cm in a tetradecane/water system.
Fenugreek has now also been found to be a preferred source of saponins, since the saponin content, based on dry weight, is 3.6% in chick peas; 4% in lentils; 5.6% in soybeans and over 6% in fenugreek [R.D. Sharma, Nutrition Reports International, "An Evaluation of Hypocholesterolemic Factor of Fenugreek Seeds (T. Foenum Graecum) in Rats," National Institute of Nutrition, Indian Council of Medical Research, Hyderabad, India].. Vol. 30 p. 21 (1984).
The invention will now be described in connection with certain preferred embodiments with reference to the following illustrative figures so that it may be more fully understood.
With specific reference now to the figures in detail, it is stressed that the particulars shown are by way of example and for purposes of illustrative discussion of the preferred embodiments of the present invention only, and are presented in the cause of providing what is believed to be the most useful and readily understood description of the principles and conceptual aspects of the invention. In this regard, no attempt is made to show structural details of the invention in more detail than is necessary for a fundamental understanding of the invention, the description taken with the drawings making apparent to those skilled in the art how the several forms of the invention may be embodied in practice.
In the drawings: Fig. 1 depicts the surface tensions of fenugreek saponins as a function of time (minutes); Fig. 2 depicts surface tensions of fenugreek saponins as a function of log c; - 8 - 109,614/2 Fig. 3 shows the interfacial tension of tetradecane/water as a function of saponin concentration; Fig. 4 shows the percent of oil separation in emulsions prepared with 20 wt.% tetradecane in water in the presence of 5 wt.% saponin-Span 80 blends, at different HLB values, aged for 7 days at 60°C; and Fig. 5 shows the average droplet size (microns) of emulsions prepared with 20 wt.% tetradecane in water in the presence of 5 wt.% saponin-Span 80 blends , at different HLB values, aged for 7 days at 60°C.
Example 1 Isolation of the Seed Fractions Dry seeds of fenugreek were purchased from the local market. The source was T. Foenum graecum, grown in India. The seeds were ground to fine powder (125 g) . The extraction was performed with Soxhlet apparatus in the presence of n-hexane for 5 hours, to give a colorless solution. The hexane solution, containing most of the lipids (1.5 g) was discarded. The solid fraction was further treated with ethanol (200 ml), followed by methanol (150 ml). The extract was vacuum evaporated and the solids were lyophilized, to yield 7-8 g of mixture of saponins. These were further treated to isolate the galactomannans, as described and claimed in Israel specification No. 108,583.
Surface and Interfacial Tensions Surface and interfacial tensions were measured with a Lauda tensiometer and platinum plate, and results were plotted against time and saponin concentrations.
Emulsification Tetradecane (20 wt.%) was emulsified in the presence of 1-5 wt.% saponin and with blends of saponins and other hydrophobic nonionic surfactants, such as Span 80 or monoglyceride oleate (MGO). The saponin performance in terms of emulsification capacity, stability, required HLB and synergistic effects in the presence of other nonionic emulsifiers, was evaluated. Each emulsion was homogenized, either by homogenizer (Ultra Turrax, Model 25, 8000-24000 rpm) or sheared in the microfluidizer (Microfluidics Corp., Model TC-110) .
Droplet size distribution was measured, using a Coulter counter (Electronic Coulter, Model TA-11, U.S.A.).
Modeling Molecular modeling was performed on a Silicon Graphics computer, using the Insight II program of Biosym Technologies on a work station type Iris 4D/240GTX.
Results The surface tension of 1 wt.% fenugreek saponin aqueous solution was plotted against time (Fig. 1). The equilibrium time required to obtain constant values is 30 to 40 minutes, stressing the fact that the saponins are monomeric surfactants with relatively high molecular weights. Each sample was therefore equilibrated for 60 minutes prior to being measured. Fig. 2 shows that fenugreek saponin can reduce surface tension to values lower than 30 dyn/cm (similar to values obtained for sugar esters). The shape of the curve resembles typical behavior of macro molecules.
The interfacial tension of tetradecane/water in the presence of fenugreek saponin was reduced to an impressive value of 8 dyn/cm surface activity, which seems to be better than other nonionic surfactants like ethoxylated sorbitan esters or sugar esters.
Fenugreek saponin characteristics are listed below in Table 1: TABLE 1 Fenugreek Saponin Characteristics Solubility in water Soluble in both cold hot water Solubility in ethanol Soluble in ethanol Surface tension 28 dyn/cm 1 wt.% Interfacial tension (with tetradecane 8 dyn/cm 1 wt.% Efficiency 3 Effectiveness 44 dyn/cm pH sensitivity low HLB 17-18 Emulsion stability 5-6 months Emulsion average drop size 5 microns The surface tensions, excess surface concentrations, efficiency, effectiveness, and surface area of the fenugreek saponin have been calculated and compared to other saponins, as presented below in Table 2.
TABLE 2 Properties of Fenugreek Saponin, Compared to Other Saponins and Selected Monomeric Surfactants Surface Excess Surface Surface Tension Concentration Area (dyn/cm) (mole/cmz) (nm)a Efficiency Effectiveness Fenugreek 28 1.57 Έ-10 1.05 3 44 Digitonin 42 1.56 -E-10 1.06 1.3 30 Sapoalbin 52 1.2Έ-10 1.37 =0 20 Soy Saponin 42 ll . O-E-10 4.02 0.7 30 The effectiveness of the saponinic fraction was superior to that of the hydrophilic ethoxylated sorbitan mono oleate (Tween 80), i.e., said fraction had an effectiveness of 44, while that of Tween 80 was only 22.
Span 80 was used as the hydrophobic surfactant to prepare blends with the extracted fenugreek saponin, in order to evaluate its emulsification power and the HLB value. The 20 wt.% tetradecane emulsions were homogenized either by rotary homogenizer or by the microfluidizer . The emulsions' average droplet sizes were monitored against time. Incubation at 60 °C, followed by measuring the percentage of oil separation, served as an additional stability tool. Figs. 3 and 4 clearly set the minimum (the best emulsification power) at HLB 17-18.
The fenugreek saponin is, therefore, very hydrophilic. The diosgenin represents 41% of the fenugreek saponins and probably dictates its surface properties. It should be noted that the best emulsions were obtained with Span 80. Ethoxylated oleyl alcohol (2EO) and sucrose distearate were non-synergistic to the fenugreek saponins, and led to unstable emulsions.
It will be evident to those skilled in the art that the invention is not limited to the details of the foregoing illustrative examples and that the present invention may be embodied in other specific forms without departing from the essential attributes thereof, and it is therefore desired that the present embodiments and examples be considered in all respects as illustrative and not restrictive, reference being made to the appended claims, rather than to the foregoing description, and all changes which come within the meaning and range of equivalency of the claims are therefore intended to be embraced therein.
Claims (3)
1. A comestible product, comprising a saponin as an emulsifying agent therein characterized in that the saponin is derived from fenugreek, said fenugreek saponin comprising a mixture of glucosidic steroids having the formula la or lb: 16 109,614/3 wherein: R,, R2 and R3 are H, CH3, H; CH3, H, H; H, CH3, OH; or CH3, H, H respectively; and R4 is hydrogen or a unit of 2-5 interconnected sugar moieties; said moieties comprising mannose, glucose, rhamnose, xylose and galactose, the saponin being obtainable by a solvent abstraction process as described herein, and having different and improved properties when compared to products produced with soybean saponins.
2. A comestible product according to claim 1, wherein said fenugreek saponins of the formula la are selected from the group consisting of tigogenin, wherein Rt is hydrogen, R2 is methyl, R3 is hydrogen and R4 includes 2-glucose, 2-galactose and 1 -xylose; neotigogenin, wherein Ri is methyl, R2 and R3 are both hydrogen and R4 includes 2-xylose, 1 -glucose and 1 -rhamnose; gitogenin. wherein Ri is hydrogen, R2 is methyl, R3 is hydroxy and R4 includes 2-galactose, 1 -xylose and 1 -glucose; and neogitogenin, wherein Rj is methyl and R2, R3 and R4 are each hydrogen.
3. A comestible product according to claim 1, wherein said fenugreek saponins of the formula lb are selected from the group consisting of diosgenin, -wherein Ri is hydrogen, R2 is methyl, R3 is hydrogen and R4 includes 1-mannose, 1 -glucose and 1 -rhamnose; yamogenin, wherein Ri is methyl, R2 and R3 are both hydrogen and R4 includes 2-rhamnose and 2-glucose; yucagenin, wherein Ri is hydrogen, R2 is methyl, R3 is hydroxy; yucagenin, wherein Ri is hydrogen, R2 is methyl, R3 is hydroxy, and lilagenin, wherein R| is methyl and R2, R3 and R4 are each hydrogen. For the Applicant WOLFF, BREGMAN AND GOLLER by:
Priority Applications (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
IL109614A IL109614A (en) | 1994-05-10 | 1994-05-10 | Comestible products containing saponins |
PCT/GB1995/000921 WO1995030341A1 (en) | 1994-05-10 | 1995-04-24 | Comestible products containing saponins |
AU23124/95A AU2312495A (en) | 1994-05-10 | 1995-04-24 | Comestible products containing saponins |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
IL109614A IL109614A (en) | 1994-05-10 | 1994-05-10 | Comestible products containing saponins |
Publications (2)
Publication Number | Publication Date |
---|---|
IL109614A0 IL109614A0 (en) | 1994-08-26 |
IL109614A true IL109614A (en) | 1998-06-15 |
Family
ID=11066122
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
IL109614A IL109614A (en) | 1994-05-10 | 1994-05-10 | Comestible products containing saponins |
Country Status (3)
Country | Link |
---|---|
AU (1) | AU2312495A (en) |
IL (1) | IL109614A (en) |
WO (1) | WO1995030341A1 (en) |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
ATE272946T1 (en) * | 1997-11-04 | 2004-08-15 | Kyowa Hakko Kogyo Kk | NEW PROTEIN COMPLEXES |
GB9923076D0 (en) | 1999-09-29 | 1999-12-01 | Phytopharm Plc | Sapogenin derivatives and their use |
US20050281936A1 (en) * | 2004-06-17 | 2005-12-22 | Unilever Bestfoods, North America | Natural food composition with stable color |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4720389A (en) * | 1986-04-22 | 1988-01-19 | Merck & Co., Inc. | Foam-stabilized malt beverage |
DE3903507C1 (en) * | 1989-02-06 | 1990-06-28 | Maizena Gmbh, 7100 Heilbronn, De |
-
1994
- 1994-05-10 IL IL109614A patent/IL109614A/en not_active IP Right Cessation
-
1995
- 1995-04-24 WO PCT/GB1995/000921 patent/WO1995030341A1/en active Application Filing
- 1995-04-24 AU AU23124/95A patent/AU2312495A/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
AU2312495A (en) | 1995-11-29 |
IL109614A0 (en) | 1994-08-26 |
WO1995030341A1 (en) | 1995-11-16 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Jahanbin et al. | Isolation, purification and characterization of a new gum from Acanthophyllum bracteatum roots | |
Hajimohammadi et al. | Production of saponin biosurfactant from Glycyrrhiza glabra as an agent for upgrading heavy crude oil | |
AU674451B2 (en) | Methods involving film-forming proteinaceous emulsion | |
Bezerra et al. | Plant-derived biosurfactants: Extraction, characteristics and properties for application in cosmetics | |
Folmer | Sterol surfactants: from synthesis to applications | |
CZ221596A3 (en) | Oil-in-water emulsion, its use and pharmaceutical composition containing thereof | |
KR100864373B1 (en) | Cosmetics containing sphingoglycolipids and a process for its production | |
JP2008019230A (en) | Ceramide-containing external preparation for skin | |
JP3586321B2 (en) | Cosmetics | |
IL109614A (en) | Comestible products containing saponins | |
EP1679007B1 (en) | Oil-in-water type emulsion food | |
CN109744325A (en) | A kind of nanoemulsion system and preparation method based on perilla oil or linseed oil | |
JPH01274830A (en) | Safe lipid composition having high surface activity | |
Tirok et al. | Behaviour of formula emulsions containing hydrolysed whey protein and various lecithins | |
US11834776B2 (en) | Process for modifying the characteristics of citrus fiber | |
JP2006199633A5 (en) | ||
TW201714603A (en) | Cosmetic composition containing soy protein emulsifier | |
JPH11199462A (en) | Sphingolipid-surfactant complex | |
JPH10231229A (en) | Cosmetic | |
KR950702825A (en) | PHARMACEUTICAL EMULSTIONS CONTAINING BIOACTIVE STEROIDS | |
Benichou et al. | Steroid-saponins from fenugreek seeds: extraction, purification and surface properties | |
Paraskevopoulou et al. | Effect of cholesterol extraction from dried yolk with the aid of Polysorbate 80 on yolk's functional properties | |
JP2007029048A (en) | Method for emulsifying phytosterol, emulsion prepared thereby and phytosterol powder product | |
TWI244376B (en) | Method of emulsifying phytosterol by natural saponins, emulsion prepared thereby and water dispersible phytosterol powder product | |
KR20100095973A (en) | Extract mixture of plants and cosmetic composition comprising the same |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FF | Patent granted | ||
KB | Patent renewed | ||
KB | Patent renewed | ||
KB | Patent renewed | ||
KB | Patent renewed | ||
MM9K | Patent not in force due to non-payment of renewal fees |